Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wexler

Showing results (141-150 of 286) with videos related to

Pageof 29
Sort By:
Diabetes Technology & Therapeutics|June 4, 2019
Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes MellitusPooyan Kazemian, Deborah J Wexler, Naomi F Fields, et al.
BMJ Open Diabetes Research & Care|September 26, 2020
Does the effect of lifestyle intervention for individuals with diabetes vary by food insecurity status? A preplanned subgroup analysis of the REAL HEALTH randomized clinical trialSeth A Berkowitz, Yuchiao Chang, Bianca Porneala, et al.
Diabetes Care|October 27, 2025
Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 DiabetesYichen E Fang, Julie M Paik, Janinne Ortega-Montiel, et al.
BMJ (Clinical Research Ed.)|June 26, 2024
SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort studyEdouard L Fu, Deborah J Wexler, Sara J Cromer, et al.
Diabetes Care|September 7, 2023
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 DiabetesAlexander Kutz, Dae Hyun Kim, Deborah J Wexler, et al.
Diabetes Research and Clinical Practice|September 6, 2020
Predictors of health facility readiness for diabetes service delivery in low- and middle-income countries: The case of BangladeshJacqueline A Seiglie, Edson Serván-Mori, Tahmina Begum, et al.
Diabetes Care|January 19, 2022
Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare BeneficiariesChelsea E Hawley, Julie C Lauffenburger, Julie M Paik, et al.
Clinical Trials (London, England)|February 7, 2012
Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trialCatherine C Beauharnais, Mary E Larkin, Adrian H Zai, et al.
The New England Journal of Medicine|July 26, 2018
Case 23-2018: A 36-Year-Old Man with Episodes of Confusion and HypoglycemiaDeborah J Wexler, Wendy Macias-Konstantopoulos, David G Forcione, et al.
Journal of Neuroscience Methods|December 14, 2001
An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and ratEric J Wexler, Elaine E Peters, Armando Gonzales, et al.
Pageof 29

Showing results (141-150 of 286) with videos related to

Sort By:
Pageof 29
Diabetes Technology & Therapeutics|June 4, 2019
Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes MellitusPooyan Kazemian, Deborah J Wexler, Naomi F Fields, et al.
BMJ Open Diabetes Research & Care|September 26, 2020
Does the effect of lifestyle intervention for individuals with diabetes vary by food insecurity status? A preplanned subgroup analysis of the REAL HEALTH randomized clinical trialSeth A Berkowitz, Yuchiao Chang, Bianca Porneala, et al.
Diabetes Care|October 27, 2025
Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 DiabetesYichen E Fang, Julie M Paik, Janinne Ortega-Montiel, et al.
BMJ (Clinical Research Ed.)|June 26, 2024
SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort studyEdouard L Fu, Deborah J Wexler, Sara J Cromer, et al.
Diabetes Care|September 7, 2023
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 DiabetesAlexander Kutz, Dae Hyun Kim, Deborah J Wexler, et al.
Diabetes Research and Clinical Practice|September 6, 2020
Predictors of health facility readiness for diabetes service delivery in low- and middle-income countries: The case of BangladeshJacqueline A Seiglie, Edson Serván-Mori, Tahmina Begum, et al.
Diabetes Care|January 19, 2022
Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare BeneficiariesChelsea E Hawley, Julie C Lauffenburger, Julie M Paik, et al.
Clinical Trials (London, England)|February 7, 2012
Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trialCatherine C Beauharnais, Mary E Larkin, Adrian H Zai, et al.
The New England Journal of Medicine|July 26, 2018
Case 23-2018: A 36-Year-Old Man with Episodes of Confusion and HypoglycemiaDeborah J Wexler, Wendy Macias-Konstantopoulos, David G Forcione, et al.
Journal of Neuroscience Methods|December 14, 2001
An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and ratEric J Wexler, Elaine E Peters, Armando Gonzales, et al.
Pageof 29